Showing 8791-8800 of 20877 results for "".
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
https://reachmd.com/programs/cme/navigating-upated-kdigo-clinical-practice-guideline-recommndations-to-maximize-proteinuria-reduction-in-patients-with-igan/26630/Explore updated KDIGO guideline recommendations and clinical strategies to reduce proteinuria in patients with IgA nephropathy.IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
https://reachmd.com/programs/cme/ibd-in-focus-a-case-based-approach-to-diagnosis-and-assessment/49150/Discuss diagnostic evaluation and severity assessment in a case of suspected IBD using clinical, laboratory, endoscopic, and imaging data.Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
https://reachmd.com/programs/cme/evaluating-use-in-pancreatic-cancer-efficacy-and-safety-data-for-on-state-ras-inhibitors/54122/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Truths and Myths About Facial Danger Zones When Injecting Soft Tissue Fillers
https://reachmd.com/programs/modern-aesthetics/truths-and-myths-about-facial-danger-zones-when-injecting-soft-tissue-fillers/39264/Despite the current dip in demand for aesthetic treatments with soft tissue fillers, minimally invasive procedures remain popular and are widely accepted as alternatives to facial surgery.Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
https://reachmd.com/programs/neurofrontiers/gut-microbiota-and-pediatric-ms-new-insights-into-potential-disease-drivers/26487/A new study investigating the relationship between gut microbiota composition and pediatric-onset multiple sclerosis (MS) offers evidence that a depletion of short-chain fatty acid (SCFA) producers may play a role in the disease's pathogenesis. Discover how these findings have the potential to inforTreatment Options for Invasive Fungal Infections: Why They Don't Always Work
https://reachmd.com/programs/cme/treatment-options-for-invasive-fungal-infections-why-they-dont-always-work/14809/Treatment options for invasive fungal infections are limited, but that’s changing. Find out what’s on the horizon and how to best fight the fungus.Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
https://reachmd.com/programs/cme/Making-the-Right-Moves-in-Metastatic-CSPC-Intensification-Imaging-and-Impact/56687/Experts discuss ADT intensification strategies, trial evidence, and patient selection for doublet and triplet therapy in metastatic CSPC.Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
https://reachmd.com/programs/clinicians-roundtable/data-ntm-lung-disease-care-challenges-impacts/54380/Even as our understanding of nontuberculous mycobacterial (NTM) lung disease advances, major gaps remain, from defining meaningful treatment success to overcoming innate drug resistance. In this conversation with Dr. Alexandria May, Dr. David Griffith shares his perspective on how recent evidence isManagement Approaches in Radiographically Isolated Syndrome
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/management-approaches-in-radiographically-isolated-syndrome/32089/How best to define radiographically isolated syndrome has been the subject of debate; challenges in determining the best management approach remain.The Clinical Significance of Imaging in the Management of ADPKD
https://reachmd.com/programs/cme/clinical-significance-imaging-management-adpkd/12675/When managing patients with autosomal dominant polycystic kidney disease, what role does radiological imaging play?